The notices it replaced
- Reissues: RFA-MH-16-425 Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01)
- 2 steps back: RFA-MH-15-340 Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01)
Replaced by RFA-MH-18-707.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,211,129 in first-year total cost, median $794,125.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-B (04)]3
- Special Emphasis Panel[ZMH1 ERB-D (04)]3
- Special Emphasis Panel[ZMH1 ERB-B (07)]2
- Special Emphasis Panel[ZMH1 ERB-D (01)]1
Most frequent institutions
- CENTRE FOR ADDICTION AND MENTAL HEALTH1
- FLORIDA STATE UNIVERSITY1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- STANFORD UNIVERSITY1
- UNIVERSITY OF CALIFORNIA BERKELEY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Investigating Social Competence in Youth with Autism: A Multisite RCT1R01MH114906-01 | CORBETT, BLYTHE ANNE | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $784,741 | ZMH1 |
| 2018 | Optimizing Long-Term Outcomes for Winter Depression with CBT-SAD and Light Therapy: Confirming the Targets, Mechanisms, and Treatment Sequence1R01MH112819-01A1 | ROHAN, KELLY J. | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $679,218 | ZMH1 |
| 2018 | Evaluating the Efficacy of Central Executive Training (CET) for ADHD1R01MH115048-01 | KOFLER, MICHAEL J | FLORIDA STATE UNIVERSITY, FL | $382,500 | ZMH1 |
| 2017 | Improving Cognition via Exercise in Schizophrenia1R01MH110623-01A1 · under RFA-MH-16-425 | KIMHY, DAVIDSTROUP, THOMAS SCOTT | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $1,555,921 | ZMH1 |
| 2017 | Confirmatory Safety and Efficacy Trial of Magnetic Seizure Therapy for Depression1R01MH112815-01 · under RFA-MH-16-425 | DASKALAKIS, ZAFIRIS J. | CENTRE FOR ADDICTION AND MENTAL HEALTH, ON | $1,542,062 | ZMH1 |
| 2017 | Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies1R01MH113617-01 · under RFA-MH-16-425 | EATON, WILLIAM WKELLY, DEANNA L | UNIVERSITY OF MARYLAND BALTIMORE, MD | $801,031 | ZMH1 |
| 2017 | Confirming the Efficacy/Mechanism of an Adaptive Treatment for Adolescent Anorexia Nervosa1R01MH110538-01A1 · under RFA-MH-16-425 | LOCK, JAMES D | STANFORD UNIVERSITY, CA | $794,125 | ZMH1 |
| 2016 | Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode1R01MH110544-01 · under RFA-MH-16-425 | NUECHTERLEIN, KEITH H | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $903,718 | ZMH1 |
| 2016 | Improving Depression Outcome by Enhancing Memory for Cognitive Therapy1R01MH108657-01A1 · under RFA-MH-16-425 | HARVEY, ALLISON G | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $767,813 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.